| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | 2009 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29,0 M € | +1.7% | 28,5 M € | +2.0% | 27,9 M € | +2.0% | 27,3 M € | -3.2% | 28,3 M € | +10.6% | 25,5 M € | +7.6% | 23,7 M € | +6.2% | 22,4 M € | +2.5% | 21,8 M € | -22.5% | 28,1 M € | +71.8% | 16,4 M € | +8.5% | 15,1 M € | +0.1% | 15,1 M € | +4.9% | 14,4 M € | +10.3% | 13,0 M € | +1.2% | 12,9 M € | — | ||
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2,3 M € | |||||||||||||||||
| EBITDA | 1,3 M € | -12.8% | 1,5 M € | -8.9% | 1,7 M € | +257.2% | 469,3 k € | -75.5% | 1,9 M € | +7.0% | 1,8 M € | +173.5% | 654,4 k € | +183.6% | -782,5 k € | -157.7% | 1,4 M € | +36.9% | 990,2 k € | -28.1% | 1,4 M € | +160.9% | 528,1 k € | -36.6% | 833,5 k € | +29.9% | 641,6 k € | -51.6% | 1,3 M € | -18.2% | 1,6 M € | +127.0% | 714,1 k € | |
| Operating profit | 912,2 k € | +18.8% | 768,1 k € | -28.1% | 1,1 M € | +523.8% | -251,9 k € | -119.3% | 1,3 M € | +4.1% | 1,3 M € | +4145.8% | 29,5 k € | +103.8% | -767,8 k € | -186.5% | 887,4 k € | +56.8% | 565,9 k € | -47.9% | 1,1 M € | +398.8% | 217,7 k € | -51.2% | 445,8 k € | +92.3% | 231,9 k € | -74.0% | 892,4 k € | -28.0% | 1,2 M € | +181.8% | 439,8 k € | |
| Profit/loss | 625,1 k € | +158.8% | 241,5 k € | -70.4% | 816,6 k € | +299.0% | -410,3 k € | -141.3% | 993,1 k € | -8.2% | 1,1 M € | +2047.9% | -55,5 k € | +90.8% | -600,1 k € | -227.9% | 469,2 k € | +108.9% | 224,6 k € | -70.0% | 749,6 k € | +491.0% | 126,8 k € | +50.2% | 84,4 k € | -78.1% | 386,2 k € | -23.5% | 504,9 k € | -17.3% | 610,4 k € | +186.0% | 213,4 k € | |
| Equity | 6,4 M € | +10.9% | 5,7 M € | -3.1% | 5,9 M € | +0.8% | 5,9 M € | -6.5% | 6,3 M € | +6.7% | 5,9 M € | +17.6% | 5,0 M € | -1.1% | 5,1 M € | -10.6% | 5,7 M € | +8.9% | 5,2 M € | +20.7% | 4,3 M € | +21.6% | 3,5 M € | -1.0% | 3,6 M € | +2.4% | 3,5 M € | +33.9% | 2,6 M € | +24.0% | 2,1 M € | +85.8% | 1,1 M € | |
| Total assets | 16,1 M € | -4.1% | 16,8 M € | +8.5% | 15,5 M € | -2.5% | 15,9 M € | -3.2% | 16,4 M € | +10.6% | 14,8 M € | +7.0% | 13,9 M € | -5.2% | 14,6 M € | +11.5% | 13,1 M € | +40.7% | 9,3 M € | +49.1% | 6,3 M € | +7.8% | 5,8 M € | -3.4% | 6,0 M € | -15.3% | 7,1 M € | +2.3% | 6,9 M € | +5.2% | 6,6 M € | +27.2% | 5,2 M € | |
| Cash | 423,0 k € | -82.0% | 2,3 M € | +114.3% | 1,1 M € | +100.0% | 547,5 k € | -13.6% | 633,5 k € | +7.7% | 588,0 k € | +22.2% | 481,2 k € | -33.1% | 719,8 k € | -71.7% | 2,5 M € | +286.6% | 658,0 k € | +21.2% | 542,9 k € | +163.9% | 205,7 k € | -21.9% | 263,5 k € | -62.9% | 710,3 k € | +59.3% | 445,9 k € | -42.0% | 769,0 k € | -19.1% | 950,0 k € | |
| Debts | 9,7 M € | -11.0% | 10,9 M € | +13.8% | 9,6 M € | -4.5% | 10,0 M € | -1.0% | 10,1 M € | +14.0% | 8,9 M € | +0.3% | 8,9 M € | -7.3% | 9,6 M € | +28.6% | 7,4 M € | +79.7% | 4,1 M € | +111.5% | 2,0 M € | -13.8% | 2,3 M € | -6.9% | 2,4 M € | -32.5% | 3,6 M € | -11.5% | 4,1 M € | -0.9% | 4,1 M € | +3.4% | 4,0 M € | |
| Staff | 88,2 | 88,9 | 90,5 | 95 | 98 | 92,8 | 94,5 | 95,2 | 88,8 | 53,5 | 33,1 | 34,7 | 33,8 | 32,1 | 33,5 | 34,1 | 39,5 | |||||||||||||||||
Public limited company · Nivelles · incorporated on 21/01/1983 · 88,2 ETP
Public limited company profitable and well capitalised. Cash position declining (-82.0%).
Solid counterparty for a standard engagement.
S.A. Laboratoires Pharmaceutiques Trenker is a Public limited company incorporated in 1983. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Nivelles. It employs on average 88,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette